"Kettering Health Greene Memorial (formerly Greene Memorial Hospital) has been dedicated to providing the community with quality affordable care. Situated in the heart of Xenia, we seek to meet the healthcare needs of patients from Jamestown, Cedarville, Yellow Springs, Waynesville, and beyond."

During the past decade, Ruth G. McMillan Cancer Center at Greene Memorial Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 146 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 27 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 71 trials, followed by "National Cancer Institute (NCI)" with 64 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "Radiation Therapy Oncology Group" with 11 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 166 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 12 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital" are "Breast Cancer" (38 trials), "Lung Cancer" (21 trials), "Lymphoma" (19 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (13 trials) and "Colorectal Cancer" (10 trials). Many other conditions were trialed in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital" are "Drug" (196 trials), "Other" (99 trials), "Biological" (88 trials), "Radiation" (41 trials) and "Procedure" (34 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "placebo" (29 trials), "Bevacizumab" (20 trials), "Paclitaxel" (18 trials) and "Quality-of-Life Assessment" (17 trials). Other intervention names were less common.

The vast majority of trials in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital" are 183 trials for "All" genders, 43 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Ruth G. McMillan Cancer Center at Greene Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 159 completed trials in Ruth G. McMillan Cancer Center at Greene Memorial Hospital, undefined suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Ruth G. McMillan Cancer Center at Greene Memorial Hospital, 5 "Phase 1" clinical trials were conducted, 113 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".